NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$5.89 and last traded at C$5.89, with a volume of 292322 shares changing hands. The stock had previously closed at C$5.75.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on NWH.UN. Royal Bank Of Canada set a C$5.50 price target on NorthWest Health Prop Real Est Inv Trust and gave the company a “sector perform” rating in a research report on Monday, November 24th. Canadian Imperial Bank of Commerce boosted their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research note on Thursday, November 13th. Scotiabank increased their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday, November 13th. Finally, BMO Capital Markets lifted their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research note on Thursday, November 13th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of C$6.00.
Read Our Latest Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Price Performance
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) last issued its earnings results on Tuesday, November 11th. The company reported C$0.06 earnings per share for the quarter. The business had revenue of C$110.69 million during the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%. As a group, research analysts expect that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current fiscal year.
NorthWest Health Prop Real Est Inv Trust Company Profile
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
Read More
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.
